Nitinol Stent Implantation Versus Percutaneous Transluminal Angioplasty in Superficial Femoral Artery Lesions up to 10 cm in Length

DOI Web Site 被引用文献18件
  • Hans Krankenberg
    From the Hamburg University Cardiovascular Center, Prof Mathey, Prof Schofer, & Partners, Hamburg, Germany (H.K., M.S., T.T.); DRK-Kliniken Berlin Westend, Institut für Klinische Radiologie, Berlin, Germany (H.J.S.); University of Leipzig Heart Center, Leipzig, Germany (D.S.); Vascular Center Berlin, Evangelisches Krankenhaus Königin Elisabeth Herzberge, Berlin, Germany (K.-L.S.); Department of Angiology, Vienna Medical University, Vienna, Austria (E.M.); Department of Cardiovascular and...
  • Michael Schlüter
    From the Hamburg University Cardiovascular Center, Prof Mathey, Prof Schofer, & Partners, Hamburg, Germany (H.K., M.S., T.T.); DRK-Kliniken Berlin Westend, Institut für Klinische Radiologie, Berlin, Germany (H.J.S.); University of Leipzig Heart Center, Leipzig, Germany (D.S.); Vascular Center Berlin, Evangelisches Krankenhaus Königin Elisabeth Herzberge, Berlin, Germany (K.-L.S.); Department of Angiology, Vienna Medical University, Vienna, Austria (E.M.); Department of Cardiovascular and...
  • Hermann J. Steinkamp
    From the Hamburg University Cardiovascular Center, Prof Mathey, Prof Schofer, & Partners, Hamburg, Germany (H.K., M.S., T.T.); DRK-Kliniken Berlin Westend, Institut für Klinische Radiologie, Berlin, Germany (H.J.S.); University of Leipzig Heart Center, Leipzig, Germany (D.S.); Vascular Center Berlin, Evangelisches Krankenhaus Königin Elisabeth Herzberge, Berlin, Germany (K.-L.S.); Department of Angiology, Vienna Medical University, Vienna, Austria (E.M.); Department of Cardiovascular and...
  • Karlheinz Bürgelin
    From the Hamburg University Cardiovascular Center, Prof Mathey, Prof Schofer, & Partners, Hamburg, Germany (H.K., M.S., T.T.); DRK-Kliniken Berlin Westend, Institut für Klinische Radiologie, Berlin, Germany (H.J.S.); University of Leipzig Heart Center, Leipzig, Germany (D.S.); Vascular Center Berlin, Evangelisches Krankenhaus Königin Elisabeth Herzberge, Berlin, Germany (K.-L.S.); Department of Angiology, Vienna Medical University, Vienna, Austria (E.M.); Department of Cardiovascular and...
  • Dierk Scheinert
    From the Hamburg University Cardiovascular Center, Prof Mathey, Prof Schofer, & Partners, Hamburg, Germany (H.K., M.S., T.T.); DRK-Kliniken Berlin Westend, Institut für Klinische Radiologie, Berlin, Germany (H.J.S.); University of Leipzig Heart Center, Leipzig, Germany (D.S.); Vascular Center Berlin, Evangelisches Krankenhaus Königin Elisabeth Herzberge, Berlin, Germany (K.-L.S.); Department of Angiology, Vienna Medical University, Vienna, Austria (E.M.); Department of Cardiovascular and...
  • Karl-Ludwig Schulte
    From the Hamburg University Cardiovascular Center, Prof Mathey, Prof Schofer, & Partners, Hamburg, Germany (H.K., M.S., T.T.); DRK-Kliniken Berlin Westend, Institut für Klinische Radiologie, Berlin, Germany (H.J.S.); University of Leipzig Heart Center, Leipzig, Germany (D.S.); Vascular Center Berlin, Evangelisches Krankenhaus Königin Elisabeth Herzberge, Berlin, Germany (K.-L.S.); Department of Angiology, Vienna Medical University, Vienna, Austria (E.M.); Department of Cardiovascular and...
  • Erich Minar
    From the Hamburg University Cardiovascular Center, Prof Mathey, Prof Schofer, & Partners, Hamburg, Germany (H.K., M.S., T.T.); DRK-Kliniken Berlin Westend, Institut für Klinische Radiologie, Berlin, Germany (H.J.S.); University of Leipzig Heart Center, Leipzig, Germany (D.S.); Vascular Center Berlin, Evangelisches Krankenhaus Königin Elisabeth Herzberge, Berlin, Germany (K.-L.S.); Department of Angiology, Vienna Medical University, Vienna, Austria (E.M.); Department of Cardiovascular and...
  • Patrick Peeters
    From the Hamburg University Cardiovascular Center, Prof Mathey, Prof Schofer, & Partners, Hamburg, Germany (H.K., M.S., T.T.); DRK-Kliniken Berlin Westend, Institut für Klinische Radiologie, Berlin, Germany (H.J.S.); University of Leipzig Heart Center, Leipzig, Germany (D.S.); Vascular Center Berlin, Evangelisches Krankenhaus Königin Elisabeth Herzberge, Berlin, Germany (K.-L.S.); Department of Angiology, Vienna Medical University, Vienna, Austria (E.M.); Department of Cardiovascular and...
  • Marc Bosiers
    From the Hamburg University Cardiovascular Center, Prof Mathey, Prof Schofer, & Partners, Hamburg, Germany (H.K., M.S., T.T.); DRK-Kliniken Berlin Westend, Institut für Klinische Radiologie, Berlin, Germany (H.J.S.); University of Leipzig Heart Center, Leipzig, Germany (D.S.); Vascular Center Berlin, Evangelisches Krankenhaus Königin Elisabeth Herzberge, Berlin, Germany (K.-L.S.); Department of Angiology, Vienna Medical University, Vienna, Austria (E.M.); Department of Cardiovascular and...
  • Gunnar Tepe
    From the Hamburg University Cardiovascular Center, Prof Mathey, Prof Schofer, & Partners, Hamburg, Germany (H.K., M.S., T.T.); DRK-Kliniken Berlin Westend, Institut für Klinische Radiologie, Berlin, Germany (H.J.S.); University of Leipzig Heart Center, Leipzig, Germany (D.S.); Vascular Center Berlin, Evangelisches Krankenhaus Königin Elisabeth Herzberge, Berlin, Germany (K.-L.S.); Department of Angiology, Vienna Medical University, Vienna, Austria (E.M.); Department of Cardiovascular and...
  • Bernhard Reimers
    From the Hamburg University Cardiovascular Center, Prof Mathey, Prof Schofer, & Partners, Hamburg, Germany (H.K., M.S., T.T.); DRK-Kliniken Berlin Westend, Institut für Klinische Radiologie, Berlin, Germany (H.J.S.); University of Leipzig Heart Center, Leipzig, Germany (D.S.); Vascular Center Berlin, Evangelisches Krankenhaus Königin Elisabeth Herzberge, Berlin, Germany (K.-L.S.); Department of Angiology, Vienna Medical University, Vienna, Austria (E.M.); Department of Cardiovascular and...
  • Felix Mahler
    From the Hamburg University Cardiovascular Center, Prof Mathey, Prof Schofer, & Partners, Hamburg, Germany (H.K., M.S., T.T.); DRK-Kliniken Berlin Westend, Institut für Klinische Radiologie, Berlin, Germany (H.J.S.); University of Leipzig Heart Center, Leipzig, Germany (D.S.); Vascular Center Berlin, Evangelisches Krankenhaus Königin Elisabeth Herzberge, Berlin, Germany (K.-L.S.); Department of Angiology, Vienna Medical University, Vienna, Austria (E.M.); Department of Cardiovascular and...
  • Thilo Tübler
    From the Hamburg University Cardiovascular Center, Prof Mathey, Prof Schofer, & Partners, Hamburg, Germany (H.K., M.S., T.T.); DRK-Kliniken Berlin Westend, Institut für Klinische Radiologie, Berlin, Germany (H.J.S.); University of Leipzig Heart Center, Leipzig, Germany (D.S.); Vascular Center Berlin, Evangelisches Krankenhaus Königin Elisabeth Herzberge, Berlin, Germany (K.-L.S.); Department of Angiology, Vienna Medical University, Vienna, Austria (E.M.); Department of Cardiovascular and...
  • Thomas Zeller
    From the Hamburg University Cardiovascular Center, Prof Mathey, Prof Schofer, & Partners, Hamburg, Germany (H.K., M.S., T.T.); DRK-Kliniken Berlin Westend, Institut für Klinische Radiologie, Berlin, Germany (H.J.S.); University of Leipzig Heart Center, Leipzig, Germany (D.S.); Vascular Center Berlin, Evangelisches Krankenhaus Königin Elisabeth Herzberge, Berlin, Germany (K.-L.S.); Department of Angiology, Vienna Medical University, Vienna, Austria (E.M.); Department of Cardiovascular and...

書誌事項

タイトル別名
  • The Femoral Artery Stenting Trial (FAST)

説明

<jats:p> <jats:bold> <jats:italic>Background—</jats:italic> </jats:bold> Endoluminal treatment of superficial femoral artery lesions is a matter of controversy. The present study was designed to investigate the impact of nitinol stenting of superficial femoral artery lesions with a maximum length of 10 cm on restenosis and clinical outcomes at 1 year. </jats:p> <jats:p> <jats:bold> <jats:italic>Methods and Results—</jats:italic> </jats:bold> Two hundred forty-four patients (168 men; 66±9 years) with a single superficial femoral artery lesion and chronic limb ischemia were randomized to implantation of a single Bard Luminexx 3 stent (123 patients) or stand-alone percutaneous transluminal angioplasty (PTA) (121 patients). Mean lesion length was 45 mm. Technical success (residual stenosis <50% for PTA, <30% for stenting) was achieved in 96 patients assigned to PTA (79%) and 117 patients assigned to stenting (95%); 13 PTA group patients (11%) “crossed over” to stenting. At 1 year, the primary end point of ultrasound-assessed binary restenosis was reached in 39 of 101 PTA group patients (38.6%) and 32 of 101 stent group patients (31.7%; absolute treatment difference, −6.9%; 95% CI, −19.7% to 6.2%; <jats:italic>P</jats:italic> =0.377). Target lesion revascularization rates at 1 year were 18.3% and 14.9%, respectively (absolute treatment difference, −3.3%; 95% CI, −13.0% to 6.4%; <jats:italic>P</jats:italic> =0.595). No statistically significant difference between treatment groups was observed at 12 months in the improvement by at least 1 Rutherford category of peripheral arterial disease. </jats:p> <jats:p> <jats:bold> <jats:italic>Conclusions—</jats:italic> </jats:bold> In the present study of patients with short superficial femoral artery lesions, the hypothesized absolute difference of 20% in binary restenosis at 1 year between the implantation of a single Luminexx nitinol stent and stand-alone PTA could not be demonstrated. A smaller difference requiring a larger trial might have been missed. </jats:p>

収録刊行物

  • Circulation

    Circulation 116 (3), 285-292, 2007-07-17

    Ovid Technologies (Wolters Kluwer Health)

被引用文献 (18)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ